$LLY · Eli Lilly and Company

Eli Lilly and Company filed a Form 4 with the SEC on October 20, 2026, reporting a change in beneficial ownership for director Gabrielle Sulzberger. The filing states that on October 19, 2026, Sulzberger acquired 3.9976 shares of Lilly common stock at a price of $1,240.34 per share.

According to the filing, the shares were acquired under the Lilly Directors’ Deferral Plan. Sulzberger elected to defer cash compensation in the form of stock units, and those units will be settled in shares of common stock after her separation from service as a director. Following the reported transaction, she directly held 3,016.4449 shares of Lilly common stock.